OTCPK:GBGPF - Post by User
Comment by
VENManon Jan 19, 2018 9:28pm
174 Views
Post# 27399075
RE:RE:RE:CMED will get either $61.44 or $93.80 per share from ACB
RE:RE:RE:CMED will get either $61.44 or $93.80 per share from ACBHIP holds the clue. Share price closed at $1.47. $1.47 / .033 = $44.55 per share offer price for both CMED and HIP. 38 million shares for both CMED and HIP X $44.55 = $1.7 Billion purchase price. HIP traded on its own for as high as $1.2 Billion. I think a friendly offer comes in at $42 to $45 per share. 3.3 for 1 all share offer. ACB would have to issue 125 million shares below the 170 million shares approved by their shareholders. 75 miliion shares below what ACB shareholders approved. (3.3 X 38 million = 125 Million Shares). ACB shares may drop from $13.3 to $11 short term when the deal is announced and CMED goes up to $42 to $45, but then ACB will move up to $15 and a Big Pharma company will step in for 20% of ACB at $11 and the stock from there will rise to $22 per share. ALL IMO!!